Bibliografia - 2ª Parte
Equipe Editorial Bibliomed
301. ROSENBERG, M.J. and ROSENTHAL, S.M. Reproductive mortality in the United States:
recent trends and methodologic considerations. American Journal of Public Health 77(7):
833–836. Jul. 1987.
302. ROSENBERG, M.J., SCHULZ, K.F., and BURTON, N. Sexually transmitted diseases in
sub-Saharan Africa. [Letter] Lancet 2(8499): 152. Jul. 19, 1986.
303. ROSENBLATT, R., ZAKIN, D., STERN, W.Z., and KUFCHER, R. Uterine perforation and
embedding by intrauterine device: evaluation by US and hysterography. Radiology 157(3):
Dec. 1985. p. 765–770.
304. ROSENFIELD, A.G. and CASTADOT, R.G. Early postpartum and immediate postabortion
intrauterine contraceptive device insertion. American Journal of Obstetrics and Gynecology
118(8): 1404–1114. Apr. 15, 1974.
305. ROSENFIELD, A.G. and VARAKAMIN, S. The postpartum approach to family planning.
American Journal of Obstetrics and Gynecology 113(1): 1–13. May 1, 1972.
306. ROSS, J.A., HONG, S., and HUBER, D.H. Voluntary sterilization: an international
fact book. New York, Association for Voluntary Sterilization, 1985. 118 p.
307. ROWE, P. (World Health Organization) [WHO randomized multicenter comparative
trials of copper IUDs] Personal communication, Feb. 1, 1988.
308. ROWE, P.J., KOETSAWANG, S., PIZARRO, E., and DIETHELM, P. Comparative bleeding
patterns of a progesterone-releasing IUD. In: Hefnawi, F. and Segal, S.J., eds. Analysis
of intrauterine contraception. Amsterdam, North- Holland, 1975. p. 185–198.
309. RUIZ, R.G. (Laboratorios Alpha) [IUD production in Mexico] Personal communication,
Dec. 21, 1987.
310. RUSLAN, S. (P.T. Kimia Farma, Jakarta, Indonesia) [IUD production in Indonesia]
Personal communication, Aug. 6, 1987.
311. RWANDA. NATIONAL OFFICE OF POPULATION (ONAPO). Rwanda 1983: Enquête Nationale sur
la Fecondite: Vol. 1. Analyse des resultats. [Rwanda 1983: National Fertility Survey: Vol.
1. Analysis of results.][FRE] Kigali, Rwanda, ONAPO, [1985]. 221 p.
312. SAGIROGLU, N. Phagocytosis of spermatozoa in the uterine cavity of women using
intrauterine device. International Journal of Fertility 16(1): 1–14. Jan.-Mar. 1971.
313. SANIEL, F.L. The Bohol IUD program. Studies in Family Planning 10(6–7):
211–212. Jun.-Jul. 1979.
314. SAURE, A., HIRVONEN, E., KIVIJÄRVI, A., and TIMONEN, H. Comparative performance
of Fincoid, Nova-T, and ML 375 IUDs. In: Zatuchni, G.I., Goldsmith, A., Sciarra, J.J., and
Osborn, C.K., eds. Intrauterine contraception: advances and future prospects.
Philadelphia, Harper & Row, 1985. p. 104–108.
315. SAYED, H.A.A.H., EL-KHORAZATY, M.N., and WAY, A.A. Fertility and family planning
in Egypt: 1984 Cairo, Egypt National Population Council, and Columbia, Maryland,
Westinghouse Public Applied Systems, Dec. 1985. 313 p.
316. SEARLE PHARMACEUTICAL GROUP (SPG). Searle discontinues IUD’s. [Press release]
Skokie, Illinois, SPG, Jan. 31, 1986. 2 p.
317. SEGAL, S.J., ALVAREZ-SANCHEZ, F., ADEJUWON, C.A., BRACHE DE MEJIA, V., LEON, P.,
and FAUNDES, A. Absence of chorionic gonadotropin in sera of women who use intrauterine
devices. Fertility and Sterility 44(2): 214–218. Aug. 1985.
318. SEGAMBA, L., NDIKUMASABO, V., TOMASSI, F. DE, and MAKINSON, C. Enquete
demographique et de sante au Burundi 1987: rapport preliminaire. [Burundi Demographic and
Health Survey 1987: preliminary report.][FRE] Ministry of the Interior, Department of
Population. and Institute for Resource Development, [Bujumbura, Burundi, and Columbia,
Maryland], 1987. 46 p.
* 319. SENANAYAKE, P. Intrauterine devices: problems encountered in family planning
programmes of developing countries. In: Diczfalusy, E. and Diczfalusy, A., eds. Research
on the regulation of human fertility: needs of developing countries and priorities for the
future: Vol. 2. Background documents. Copenhagen, Scriptor, 1983. p. 433–448.
320. SHAW, S.T., Jr., ANDRADE, A.T.L., PAIXAO DE SOUZA, J., MACAULAY, L.K., and ROWE,
P.J. Quantitative menstrual and intermenstrual blood loss in women using Lippes Loop and
Copper T intrauterine devices. Contraception 21(4): 343–352. Apr. 1980.
321. SHELTON, J. (US Agency for International Development) [Price of contraceptives]
Personal communication, Feb. 5, 1988.
322. SHEPPARD, B.L. Endometrial morphological changes in IUD users: a review.
Contraception 36(1): 1–10. Jul. 1987.
323. SHEPS, M.C. An analysis of reproductive patterns in an American isolate.
Population Studies 15: 65–80. 1965–1966.
324. SIEDLECKY, S. Current usage of and attitudes towards contraception in Australia.
Healthright 6(1): 7–16. Nov. 1986.
325. SIMONS, P. (Family Planning Federation of Australia) [Contraceptive use in
Australia] Personal communication, Jun. 24, 1987.
326. SINEI, S.K.A., SCHULZ, K.F., et al. Preventing IUD-related pelvic infection: the
efficacy of prophylactic doxycycline at insertion. Dec. 10, 1987. 28 p. (Unpublished)
* 327. SIVIN, I. IUD-associated ectopic pregnancies, 1974 to 1984. In: Zatuchni, G.I.,
Goldsmith, A., Sciarra, J.J., and OSBORN, C.K., eds. Intrauterine contraception: advances
and future prospects. Philadelphia, Harper & Row, 1985. p. 340–353.
328. SIVIN, I. The intrauterine device and uterine perforation. [Letter] Obstetrics and
Gynecology 64(5): 744–745. Nov. 1984.
329. SIVIN, I. (Population Council) [Anemia rates among 5-year TCu-380Ag users]
Personal communication, Jan. 18, 1988.
330. SIVIN, I. (Population Council) [Ectopic pregnancy rates with the TCu-380A and the
LNG-20 IUDs] Personal communication, May 22, 1987.
* 331. SIVIN, I. and SCHMIDT, F. Effectiveness of IUDs: a review. Contraception 36(1):
55–85. Jul. 1987.
332. SIVIN, I. and STERN, J. Long-acting, more effective Copper T IUDs: a summary of
U.S. experience, 1970–75. Studies in Family Planning 10(10): 263–281. Oct. 1979.
333. SIVIN, I. and TATUM, H.J. Four years of experience with the TCu 380A intrauterine
contraceptive device. Fertility and Sterility 36(2): 159–163. Aug. 1981.
334. SIVIN, I., ALVAREZ, F., DIAZ, J., DIAZ, S., MAHGOUB, S., EL-., COUTINHO, E.,
BRACHE, V., DIAZ, M.M., FAUNDES, A., PAVEZ, M., MATTOS, C.E.R., and STERN, J. Intrauterine
contraception with copper and with levonorgestrel: randomized study of the TCu 380Ag and
Levonorgestrel 20 mg/day devices. Contraception 30(5): 443–456. Nov. 1984.
335. SIVIN, I., STERN, J., DIAZ, J., et. al. Two years of intrauterine contraception
with levonorgestrel and with copper: a randomized comparison of the TCu 380Ag and
levonorgestrel 20 mg/day devices. Contraception 35(3): 245–255. Mar. 1987.
336. SKANGALIS, M., MAHONEY, C.J., and O’LEARY, W.M. Microbial presence in the
uterine cavity as affected by varieties of intrauterine contraceptive devices. Fertility
and Sterility 37(2): 263–269. Feb. 1982.
337. SKJELDESTAD, F.E. and BRATT, H. Return of fertility after use of IUDs (Nova-T,
MLCu250 and MLCu375). Advances in Contraception 3(2): 139–145. Jun. 1987.
338. SKRZYCKI, C. and GALLAGHER, M.H. The risky business of birth control. U.S. News
& World Report, May 1986. p. 1–2.
339. SMITH, M.R. and SODERSTROM, R. Salpingitis: a frequent response to intrauterine
contraception. Journal of Reproductive Medicine 16(4): 159–162. Apr. 1976.
340. SNOWDEN, R. General assessment of the Multiload Cu250 intrauterine device: UK
network of IUCD research clinics. British Journal of Obstetrics and Gynaecology (Suppl.
4): 58–65. Sep. 1982.
* 341. SNOWDEN, R. The I.U.D.: a woman’s guide. London, Unwin Paperbacks, 1986.
127 p.
342. SNOWDEN, R. (Institute of Population Studies. University of Exeter, UK) [Frequency
of missing IUD strings] Personal communication, Sep. 21, 1987.
343. SNOWDEN, R. and PEARSON, B. Pelvic infection: a comparison of the Dalkon Shield
and three other intrauterine devices. British Medical Journal 288(6430): 1570–1573.
May 26, 1984.
344. SNOWDEN, R., WILLIAMS, M., and HAWKINS, D. The IUD: a practical guide. London,
Croom Helm, 1977. 113 p.
345. SOCIEDADE CIVIL BEM-ESTAR FAMILIAR NO BRASIL (BEMFAM). and INSTITUTE FOR RESOURCE
DEVELOPMENT, WESTINGHOUSE (IRD). Brazil demographic and health survey, 1986: preliminary
report. [Brasília, Brazil], BEMFAM and [Columbia, Maryland], IRD, Dec. 1986. 33 p.
346. SODERBERG, G. and LINDGREN, S. Influence of an intrauterine device on the course
of an acute salpingitis. Contraception 24(2): 137–143. Aug. 1981.
347. SOLÍS, J.A. (Pan American Health Organization) [IUD supplies, 1982–87]
Personal communication, Jul. 28, 1987.
348. SONI, V. Thirty years of the Indian family planning program: past performance,
future prospects. International Family Planning Perspectives 9(2): 35–45. Jun. 1983.
349. SPAIN. NATIONAL INSTITUTE OF STATISTICS (NIS). Encuesta de fecundidad 1985: avance
de resultados. [Fertility survey 1985: advance results.] [Madrid], Spain, NIS, 1986. 237
p.
350. SPARKS, R.A., PURRIER, B.G.A., WATT, P.J., and ELSTEIN, M. Bacteriological
colonisation of uterine cavity: role of tailed intrauterine contraceptive device. British
Medical Journal 282: 1189–1191. Apr. 11, 1981.
351. SPIELER, J.M. Discussion: governmental regulatory agencies and IUDs. In: Zatuchni,
G.I., Goldsmith, A., and Sciarra, J.J., eds. Intrauterine contraception: advances and
future prospects. Philadelphia, Harper & Row, 1985. p. 67–68.
352. SPORNITZ, U.M., MAKABE, S., HAFEZ, E.S.E., and VAN OS, W.A.A. Scanning electron
microscopy of the IUD tail. Contraceptive Delivery Systems 5(1): 29–45. Jan. 1984.
353. SRI LANKA. MINISTRY OF HEALTH (MOH). FAMILY HEALTH BUREAU. and FAMILY PLANNING
ASSOCIATION OF SRI LANKA (FPASR). An experimental operations research field study to
increase IUD acceptance in Sri Lanka. Colombo, Sri Lanka, MOH and FPASR, Oct. 1985. 53 p.
354. SRI LANKA. MINISTRY OF PLAN IMPLEMENTATION (MPI). DEPARTMENT OF CENSUS AND
STATISTICS. and INSTITUTE FOR RESOURCE DEVELOPMENT/WESTINGHOUSE (IRD/W). Sri Lanka
Demographic and Health Survey 1987, preliminary report. Sri Lanka, MPI, Jul. 1987. 23 p.
355. STADEL, B. (US Food and Drug Administration) [Actinomyces in long-term IUD users]
Personal communication, Jan. 28, 1988.
356. STADEL, B.V. and SCHLESSELMAN, S. Extent of surgery for pelvic inflammatory
disease in relation to duration of intrauterine device use. Obstetrics and Gynecology
63(2): 171–178. Feb. 1984.
357. STATE UNIVERSITY OF NEW YORK (SUNY). Family planning procedure manual for
nurse-midwives 1982. [Albany, New York, SUNY, 1982]. 161 p.
358. STEVEN, J.D. and FRASER, I.S. The outcome of pregnancy after failure of an
intrauterine contraceptive device. Journal of Obstetrics and Gynaecology 81: 282–284.
Apr. 1974.
359. STONE, K.M., GRIMES, D.A., and MAGDER, L.S. Personal protection against sexually
transmitted diseases. American Journal of Obstetrics and Gynecology 155(1): 180–188.
Jul. 1986.
360. STRUTHERS, B.J. Pelvic inflammatory disease, intrauterine contraception, and the
conduct of epidemiologic studies. Advances in Contraception 1(1): 63–76. 1985.
361. STUMPF, P.G. and LENKER, R.M. Insertion technique, not design, affects expulsion
rates of postpartum intrauterine device. Contraception 30(4): 327–330. Oct. 1984.
362. SUMBUNG, P.P. The role of the IUD in the Indonesian National Family Planning
Program. Jakarta, National Family Planning Coordinating Board, Sep. 1985. (Technical
Reports Series Monograph No. 45) 22 p.
363. SUNG S., QIAN L.-J., and LIU X. Comparative clinical experience with 3 IUDs, TCu
380 Ag, TCu 220C and Mahua Ring, in Tianjin, People’s Republic of China.
Contraception 29(3): 229–239. Mar. 1984.
364. SUNG S., QIAN L.-J., and LIU X. Two-year comparative clinical experience with
three IUDs in China. In: Zatuchni, G.I., Goldsmith, A., Sciarra, J.J., and Osborn, C.K.,
eds. Intrauterine contraception: advances and future prospects. Philadelphia, Harper &
Row, 1985. p. 109–114.
365. SWEDEN. NATIONAL CENTRAL BUREAU OF STATISTICS (NCBS). Kvinnor och barn: intervjuer
med kvinnor om familj och arbete. [Women and children: interviews with women about family
and work.][SWE] Stockholm, NCBS, 1982. 101 p.
366. SWEET, R.L. and GIBBS, R.S. Infectious diseases of the female genital tract.
Baltimore, Williams & Wilkins, 1985. 373 p.
367. TATUM, H. (Emory University) [Research on the postpartum TCu-380A IUD] Personal
communication, Sep. 18, 1987.
* 368. TATUM, H.J. and CONNELL, E.B. A decade of intrauterine contraception: 1976 to
1986. Modern Trends 46(2): 173–192. Aug. 1986.
369. TATUM, H.J. and SCHMIDT, F.H. Contraceptive and sterilization practices and
extrauterine pregnancy: a realistic perspective. Fertility and Sterility 28(4):
407–421. Apr. 1977.
370. TATUM, H.J. and ZIPPER, J.A. The "T" intrauterine contraceptive device
and recent advances in hormonal anticonceptional therapy. Presented at the 6th Northeast
Obstetrics-Gynecology Congress, Bahia, Brazil, Oct. 4–9, 1968. 6 p.
371. TATUM, H.J., SCHMIDT, F.H., and JAIN, A.K. Management and outcome of pregnancies
associated with the Copper T intrauterine contraceptive device. American Journal of
Obstetrics and Gynecology 126(7): 869–879. Dec. 1, 1976.
372. TATUM, H.J., SCHMIDT, F.H., PHILLIPS, D., MCCARTY, M., and O’LEARY, W.M. The
Dalkon Shield controversy: structural and bacteriological studies of IUD tails. Journal of
the American Medical Association 231(7): 711–717. Feb. 17, 1975.
373. THIERY, M. Immediate postpartum insertion of IUDs. IPPF Medical Bulletin 15(3):
1–2. Jun. 1981.
* 374. THIERY, M. Intrauterine contraception: technical advances, future prospects.
Network 8(2): 3. Winter 1987.
375. THIERY, M. Timing of IUD insertion. In: Zatuchni, G.I., Goldsmith, A., Sciarra,
J.J., and Osborn, C.K., eds. Intrauterine contraception: advances and future prospects.
Philadelphia, Harper & Row, 1985. p. 365–374.
376. THIERY, M. and KOSONEN, A. The multisleeved Copper T model TCu220C: effect of
long-term use on corrosion and dissolution of copper. Contraception 35(2): 163–170.
Feb. 1987.
377. THIERY, M., LAUFE, L., PAREWIJCK, W., VAN DER PAS, H., VAN KETS, H., DEROM, R.,
and DEFOORT, P. Immediate postplacental IUD insertion: a randomized trial of sutured
(Lippes Loop and TCu220C) and non-sutured (TCu220C) models. Contraception 28(4):
299–313. Oct. 1983.
378. THIERY, M., MARTENS, G., and VAN DER EECKEN, A. Iron stores in users of oral and
intrauterine contraception. IRCS Medical Science 14: 725. 1986.
379. THIERY, M., VAN DER PAS, H., and VAN KETS, H. A decade of experience with the
TCu220C. Advances in Contraception 1: 313–318. 1985.
380. THIERY, M., VAN DER PAS, H., and VAN KETS, H. The MLCu375 intrauterine
contraceptive device. Advances in Contraception 1: 37–44. 1985.
381. THIERY, M., VAN DER PAS, H., DELBEKE, L., and VAN KETS, H. Comparative performance
of two copper-wired IUDs (ML Cu 250 and T Cu 200): immediate postpartum and interval
insertion. Contraceptive Delivery Systems 1(1): 27–35. Jan. 1980.
382. THIERY, M., VAN KETS, H., and VAN DER PAS, H. Immediate postplacental IUD
insertion: the expulsion problem. Contraception 31(4): 331–349. Apr. 1985.
383. THIERY, M., VAN KETS, H., VAN DER PAS, H., VAN OS, W., and DOMBROWICZ, N. The ML
Cu250; clinical experience in Belgium and the Netherlands. British Journal of Obstetrics
and Gynaecology (Suppl. 4): 51–53. Sep. 1982.
384. TIETZE, C. What price fertility control? Lower than that of unwanted pregnancy.
Contemporary Ob/Gyn 12(1): 32–37. Jul. 1978.
385. TIETZE, C. and LEWIT, S. Evaluation of intrauterine devices: ninth progress report
of the cooperative statistical program. Studies in Family Planning 55: 1–40. Jul.
1970.
386. TREDWAY, D.R., UMEZAKI, C.U., MISHELL, D.R., Jr., and SETTLAGE, D.S.F. Effect of
intrauterine devices on sperm transport in the human being: preliminary report. American
Journal of Obstetrics and Gynecology 123(7): 734–735. Dec. 1, 1975.
387. TRUSSELL, J. and KOST, K. Contraceptive failure in the United States: a critical
review of the literature. Studies in Family Planning 18(5): 237–283. Sep.-Oct. 1987.
388. TUNÇBILEK, E., ÜNER, S., TOROS, A., CERIT, S., ULUSOY, M., AYHAN, Ö., PEKER,
M., AKADLI, B., HANCIOGLU, A., KULU, I., and ÜNALAN, T. 1983 Turkish population and
health survey. Ankara, Turkey, Hacettepe University, 1987. 117 p.
389. TUOMIVAARA, L., KAUPPILA, A., and PUOLAKKA, J. Ectopic pregnancy—an analysis
of the etiology, diagnosis and treatment in 552 cases. Archives of Gynecology 237(3):
135–147. Jan. 1986.
390. UNITED KINGDOM. OFFICE OF POPULATION CENSUSES AND SURVEYS. Contraception,
sterilisation and infertility. In: General Household Survey 1983. London, Her
Majesty’s Stationery Office, 1985. (Series GHS No. 13) p. 45–60.
391. UNITED NATIONS (UN). POPULATION DIVISION. OFFICE FOR DEVELOPMENT RESEARCH AND
POLICY ANALYSIS. World population trends and policies: 1987 monitoring report. [New York],
UN, 802 p. (ESA/P/WP.97; 86–34827) Dec. 18, 1986.
392. UNITED NATIONS FUND FOR POPULATION ACTIVITIES (UNFPA). Viet Nam: report of second
mission on needs assessment for population assistance. New York, UNFPA, Mar. 1983. (Report
No. 53) 59 p.
393. UNITED NATIONS FUND FOR POPULATION ACTIVITIES. Needs assessment: maternal and
child health and family planning: Democratic People’s Republic of Korea. [1984]. 17
p. (Unpublished)
394. UNITED NATIONS. ECONOMIC AND SOCIAL COMMISSION FOR ASIA AND THE PACIFIC (ESCAP).
The use of contraception in the Asian and Pacific region. Population Research Leads, No.
21. 1985. 31 p.
395. UNITED STATES. CENTERS FOR DISEASE CONTROL (CDC). Family planning methods and
practice: Africa. Atlanta, Georgia, CDC, 1983. 329 p.
396. UNITED STATES. CENTERS FOR DISEASE CONTROL. Recommendations for prevention of HIV
transmission in health-care settings. Morbidity and Mortality Weekly Report 36(2S):
3S–18S. Aug. 21, 1987.
397. UNITED STATES. CENTERS FOR DISEASE CONTROL. 1985 STD treatment guidelines.
Morbidity and Mortality Weekly Report 34(4S): 75S–108S. Oct. 18, 1985.
* 398. UNITED STATES. DEPARTMENT OF HEALTH AND HUMAN SERVICES. CENTERS FOR DISEASE
CONTROL (CDC). IUDs: guidelines for informed decision-making and use. Atlanta, Georgia,
CDC, May 1, 1987. 14 p. (Mimeo)
399. UNITED STATES. DEPARTMENT OF HEALTH AND HUMAN SERVICES. CENTERS FOR DISEASE
CONTROL (CDC). Sexually transmitted diseases summary 1986. [Poster] Atlanta, Georgia, CDC,
1986.
400. UNITED STATES. DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE. FOOD AND DRUG
ADMINISTRATION (FDA). Progestasert IUD and ectopic pregnancy. FDA Drug Bulletin 8(6): 37.
Dec. 1978-Jan. 1979.
401. UNITED STATES. DEPARTMENT OF STATE. Population: status of IUDs. [Telegram to AID
worldwide] 1986. 1 p. (Unpublished)
402. UNITED STATES. DEPARTMENT OF STATE. Population: withdrawal of copper IUDs from the
U.S. market. [Telegram to AID worldwide] Feb. 1986. 2 p. (Unpublished)
403. UNITED STATES. TORT POLICY WORKING GROUP (TPWG). Report of the Tort Policy Working
Group on the causes, extent and policy implications of the current crisis in insurance
availability and affordability. [Washington, D.C.], TPWG, Feb. 1986. 80 p.
404. VAN DE GIESSEN, G.J. Onderzoek Gezinsvorming 1982: voorlopige uitkomsten.
[Netherlands Fertility Survey 1982: provisional results.][DUT, summary in ENG]
Maandstatistiek van de Bevolking 31(4–5): 38–53. Apr.-May 1983.
405. VAN DER PAS, H., THIERY, M., DELBEKE, L., VAN KETS, H., and HASPELS, A. Six
years’ experience with the T Cu 220C intrauterine contraceptive device. Contraceptive
Delivery Systems 1(1): 1–10. Jan. 1980.
406. VAN DER PAS, H., THIERY, M., VAN KETS, H., and PAREWIJCK, W. The Ombrelle-380 IUD:
a pilot study. Advances in Contraception 3(1): 37–41. Mar. 1987.
407. VAN DER PAS, H., WILDEMEERSCH, D., THIERY, M., VAN KETS, H., and PAREWIJCK, W. The
CU-FIX 360 IUD. Advances in Contraception 3(3): 193–194. Sep. 1987.
408. VAN DER VURST, J. Anticonceptie in Vlaanderen. [Contraception in Flanders.][DUT]
[Dissertation: Utrecht, Rijksuniversiteit, 1985]. p. 249–324.
409. VAN KETS, H., THIERY, M., and VAN DER PAS, H. IUD insertion during cesarean
section. Advances in Contraception 1: 337–340. 1985.
410. VAN KETS, H., THIERY, M., VAN DER PAS, H., and PAREWIJCK, W. Immediate postpartum
insertion: performance of the Nova-T-PP and randomized comparison with the Nova-T.
Advances in Contraception 3(1): 63–69. Mar. 1987.
* 411. VAN OS, W.A.A. The Multiload intrauterine device: development and evaluation.
Doctoral dissertation, Rijks University of Utrecht, The Netherlands, 1987. 139 p.
412. VAN OS, W.A.A. (Elizabeth Gasthuis, Haarlem, The Netherlands) [Research on new
Multiload IUDs and frameless IUDs] Personal communication, Jul. 20, 1987.
413. VESSEY, M., MEISLER, L., FLAVEL, R., and YEATES, D. Outcome of pregnancy in women
using different methods of contraception. British Journal of Obstetrics and Gynaecology
86(7): 548–556. Jul. 1979.
* 414. VESSEY, M.P., LAWLESS, M., MCPHERSON, K., and YEATES, D. Fertility after
stopping use of intrauterine contraceptive device. British Medical Journal 286: 106. Jan.
8, 1983.
415. VESSEY, M.P., YEATES, D., FLAVEL, R., and MCPHERSON, K. Pelvic inflammatory
disease and the intrauterine device: findings in a large cohort study. British Medical
Journal 282(6267): 855–857. Mar. 14, 1987.
416. VIDELA-RIVERO, L., ETCHEPAREBORDA, J.J., and KESSERU, E. Early chorionic activity
in women bearing inert IUD, copper IUD and levonorgestrel-releasing IUD. Contraception
36(2): 217–226. Aug. 1987.
417. VILLA-REAL, H.M. (United Nations Fund for Population Activities (UNFPA)) [UNFPA
IUD supplies, 1983–87] Personal communication, Jul. 10, 1987.
418. WASHINGTON, A.E., SWEET, R.L., and SHAFER, M.-A. B. Pelvic inflammatory disease
and its sequelae in adolescents. Journal of Adolescent Health Care 6(4): 298–310.
Jul. 1985.
419. WASSERHEIT, J. (Johns Hopkins Medical School and Baltimore City Health Department)
[Genital infections and IUD insertion] Personal communication, Feb. 12 and 29, 1988.
420. WASSERHEIT, J.N. Pelvic inflammatory disease and infertility. Maryland Medical
Journal 36(1): 58–63. Jan. 1987.
421. WESTRÖM, L. Incidence, prevalence, and trends of acute pelvic inflammatory
disease and its consequences in industrialized countries. American Journal of Obstetrics
and Gynecology 138(7, Pt. 2): 880–892. Dec. 1, 1980.
* 422. WESTRÖM, L. Pelvic inflammatory disease: bacteriology and sequelae.
Contraception 36(1): 111–128. Jul. 1987.
423. WESTRÖM, L. and MÅRDH, P.-A. Current views on the concept of pelvic inflammatory
disease. Australian and New Zealand Journal of Obstetrics and Gynaecology 24(2):
98–105. May 1984.
424. WESTRÖM, L., BENGTSSON, L.P., and MARDH, P.-A. Incidence, trends, and risks of
ectopic pregnancy in a population of women. British Medical Journal 282(6257): 15–18.
Jan. 3, 1981.
425. WHEELER, R.G., COLE, L.P., and GALVEZ, R.S. IUDs with or without strings. In:
Zatuchni, G.I., Goldsmith, A., and Sciarra, J.J., eds. Intrauterine contraception:
advances and future prospects. Philadelphia, Harper & Row, 1984. p. 420–426.
426. WHITE, M.K., ORY, H.W., ROOKS, J.B., and ROCHAT, W. Intrauterine device
termination rates and the menstrual cycle day of insertion. Obstetrics and Gynecology
55(2): 220–224. Feb. 1980.
427. WILCOX, A.J., WEINBERG, C.R., ARMSTRONG, E.G., and CANFIELD, R.E. Urinary human
chorionic gonadotropin among intrauterine device users: detection with a highly specific
and sensitive assay. Fertility and Sterility 47(2): 265–269. Feb. 1987.
428. WILLSON, J.R., LEDGER, W.J., BOLLINGER, C.C., and ANDROS, G.J. The Margulies
intrauterine contraceptive device. American Journal of Obstetrics and Gynecology 92(1):
62–70. May 1, 1965.
429. WILSON, A. (Development Associates) [Training and role of paramedics in IUD
programs] Personal communication, Oct. 16, 1987.
430. WILSON, J. A randomized trial of the Nova T, the MLCu375, and the MLAgCu250 IUDs:
1 and 2 year results. Advances in Contraception 2(3): 247–248. Sep. 1986.
431. WILSON, J.C. A prospective New Zealand study of fertility after the removal of
copper IUDs for conception and for complications: a 4 year study. [1987]. 19 p.
(Unpublished)
432. WILSON, J.C. A randomized comparative study of 3 IUDs: Nova-T, ML Cu 375 and ML Ag
Cu 250 in New Zealand: 1 year results. Aug. 31, 1987. 12 p. (Unpublished)
433. WINIKOFF, B., SEMERARO, P., and ZIMMERMAN, M. Contraception during breastfeeding:
a clinician’s sourcebook. [New York], Population Council, [1988]. 36 p.
434. WOLF, A.S. and KRIEGER, D. Bacterial colonization of intrauterine devices (IUDs).
Archives of Gynecology 239(1): 31–37. 1986.
* 435. WORLD HEALTH ORGANIZATION (WHO). Guidelines for sterilization and high level
disinfection methods effective against human immunodeficiency virus (HIV). Geneva, WHO,
Jan. 22, 1988. 11 p.
* 436. WORLD HEALTH ORGANIZATION (WHO). Intrauterine devices: their role in family
planning care. Geneva, WHO, 1983. (WHO Offset Publication No. 75) 53 p.
* 437. WORLD HEALTH ORGANIZATION (WHO). Mechanism of action, safety and efficacy of
intrauterine devices. Geneva, WHO, 1987. (Technical Report Series 753) 91 p.
438. WORLD HEALTH ORGANIZATION (WHO). SPECIAL PROGRAMME OF RESEARCH, DEVELOPMENT AND
RESEARCH TRAINING IN HUMAN REPRODUCTION AND SPECIAL PROGRAMME ON AIDS. Report of a meeting
on contraceptive methods and HIV infections. Geneva, WHO, Jun. 1987. 21 p.
439. WORLD HEALTH ORGANIZATION (WHO). SPECIAL PROGRAMME OF RESEARCH, DEVELOPMENT AND
RESEARCH TRAINING IN HUMAN REPRODUCTION. Ninth annual report. Geneva, WHO, Dec. 1980. 162
p.
440. WORLD HEALTH ORGANIZATION (WHO). SPECIAL PROGRAMME OF RESEARCH, DEVELOPMENT AND
RESEARCH TRAINING IN HUMAN REPRODUCTION. Tenth annual report. Geneva, WHO, Nov. 1981. 67
p.
441. WORLD HEALTH ORGANIZATION (WHO). TASK FORCE ON METHODS FOR THE REGULATION OF
IMPLANTATION. and NEWTON, J., SZONTAGH, F., LEBECH, P., and ROWE, P. A collaborative study
of the progesterone intrauterine device (Progestasert). Contraception 19(6): 575–589.
Jun. 1979.
* 442. WORLD HEALTH ORGANIZATION. SPECIAL PROGRAMME OF RESEARCH, DEVELOPMENT AND
RESEARCH TRAINING IN HUMAN REPRODUCTION. TASK FORCE ON INTRAUTERINE DEVICES FOR FERTILITY
REGULATION. A multinational case-control study of ectopic pregnancy. Clinical Reproduction
and Fertility 3(2): 131–143. Jun. 1985.
443. WORLD HEALTH ORGANIZATION. SPECIAL PROGRAMME OF RESEARCH, DEVELOPMENT AND RESEARCH
TRAINING IN HUMAN REPRODUCTION. TASK FORCE ON INTRAUTERINE DEVICES FOR FERTILITY
REGULATION. Comparative multicentre trial of three IUDs inserted immediately following
delivery of the placenta. Contraception 22(1): 9–18. Jul. 1980.
444. WORLD HEALTH ORGANIZATION. SPECIAL PROGRAMME OF RESEARCH, DEVELOPMENT AND RESEARCH
TRAINING IN HUMAN REPRODUCTION. TASK FORCE ON INTRAUTERINE DEVICES FOR FERTILITY
REGULATION. Interval IUD insertion in parous women: a randomized multicentre comparative
trial of the Lippes Loop D, TCu220C and the Copper 7. Contraception 26(1): 1–22. Jul.
1982.
445. WORLD HEALTH ORGANIZATION. SPECIAL PROGRAMME OF RESEARCH, DEVELOPMENT AND RESEARCH
TRAINING IN HUMAN REPRODUCTION. TASK FORCE ON INTRAUTERINE DEVICES FOR FERTILITY
REGULATION. IUD insertion following spontaneous abortion: a clinical trial of the TCu
220C, Lippes Loop D, and Copper 7. Studies in Family Planning 14(4): 109–114. Apr.
1983.
* 446. WORLD HEALTH ORGANIZATION. SPECIAL PROGRAMME OF RESEARCH, DEVELOPMENT AND
RESEARCH TRAINING IN HUMAN REPRODUCTION. TASK FORCE ON INTRAUTERINE DEVICES. PID
associated with fertility regulating agents. Contraception 30(1): 1–21. Jul. 1984.
447. WORLD HEALTH ORGANIZATION. SPECIAL PROGRAMME OF RESEARCH, DEVELOPMENT AND RESEARCH
TRAINING IN HUMAN REPRODUCTION. TASK FORCE ON INTRAUTERINE DEVICES FOR FERTILITY
REGULATION. The Alza T IPCS 52, a longer acting progesterone IUD: safety and efficacy
compared to the TCu220C and Multiload 250 in two randomized multicentre trials. Clinical
Reproduction and Fertility 2(2): 113–128. Jun. 1983.
448. WRIGHT, N.H., SUJPLUEM, C., ROSENFIELD, A.G., and VARAKAMIN, S. Nurse-midwife
insertion of the Copper T in Thailand: performance, acceptance, and programmatic effects.
Studies in Family Planning 8(9): 237–243. Sep. 1977.
449. ZAKIN, D., STERN, W.Z., and ROSENBLATT, R. Complete and partial uterine
perforation and embedding following insertion of intrauterine devices: 2. Diagnostic
methods, prevention, and management. Obstetrical and Gynecological Survey 36(8):
401–417. Aug. 1981.
450. ZAKIN, D., STERN, W.Z., and ROSENBLATT, R. Complete and partial uterine
perforation and embedding following insertion of intrauterine devices: 1. Classification,
complications, mechanism, incidence, and missing string. Obstetrical and Gynecological
Survey 36(7): 335–353. Jul. 1981.
451. ZHANG, P.-Z. Five years experience with the Copper T 200 in Shanghai: 856 cases.
Contraception 22(6): 561–571. Dec. 1980.
452. ZHU, S.-M. The copper intrauterine device: copper corrosion in utero and the
effects of the copper ion on some enzyme activities. In: Chang, C.F., Griffin, D., and
Woolman, A., ed. Recent advances in fertility regulation: proceedings of a symposium
organized by the Ministry of Public Health of the People’s Republic of China, and the
World Health Organization’s Special Programme of Research Development and Research
Training in Human Reproduction, Beijing, Sep. 2–5, 1980. Geneva, Atar, 1981. p.
248–264.
453. ZIPPER, J., MEDEL, M., GOLDSMITH, A., and EDELMAN, D.A. Six-year continuation
rates for CU-T-200 users. Journal of Reproductive Medicine 18(2): 95–97. Feb. 1977.
454. ZIPPER, J.A., TATUM, H.J., PASTENE, L., MEDEL, M., and RIVERA, M. Metallic copper
as an intrauterine contraceptive adjunct to the "T" device. American Journal of
Obstetrics and Gynecology 105(8): 1274–1278. Dec. 15, 1969.
Addenda
455. AMSEL, R., TOTTEN, P.A., SPIEGEL, C.A., CHEN, K.C.S., ESCHENBACH, D., and HOLMES,
K.K. Nonspecific vaginitis: diagnostic criteria and microbial and epidemiologic
associations. American Journal of Medicine 74(1): 14-22. Jan. 1983.
456. BOUHAFA, M. Draft team member contributions to mid-term evaluation of the
Population and Family Planning Project (608–0171) in Morocco. Mar. 1988. 13 p.
(Unpublished)
457. BRUNO, K. (G.D. Searle and Company) [Lawsuits on the Cu-7 IUD] Personal
communication, Mar. 23, 1988.
458. CATES, W. (US CDC) [Genital infections and IUD insertion] Personal communication,
Apr. 21, 1988.
459. CAVANAGH, D. and COMAS, M.R. Spontaneous abortion. In: Danforth, D.N., ed.
Obstetrics and Gynecology. 4th ed. Philadelphia, Harper & Row, 1982. p. 378–392.
460. DEMAEYER, E. and ADIELS-TEGMAN, M. The prevalence of anaemia in the world. World
Health Statistics Quarterly 38(3): 302–316. 1985.
461. FINISHING ENTERPRISES. Prescribing information: Lippes Loop intrauterine
contraceptive device. [Package insert] New York, Finishing Enterprises, 1987. 1 p.
462. KIRSHON, B., POINDEXTER, A.N., 3rd, and SPITZ, M.R. Pelvic adhesions in
intrauterine device users. Obstetrics and Gynecology 71(2): 251–254. Feb. 1988.
463. KOZUH NOVAK, M., ANDOLSEK, L., BALOGH, S.A., and WASZAK, C.S. Long-term use of
intrauterine devices. IPPF Medical Bulletin 22(1): 1–3. Feb. 1988.
464. LARSON, N. (GynoPharma, Inc.) [Market research to develop the brand name ParaGard]
Personal communication, Apr. 18, 1988.
465. LARSSON, B. and FIANU, S. Long-term use of a Progestasert System, a
progesterone-releasing intrauterine device, in treatment of menorrhagia. Current
Therapeutic Research 33(6): 869–873. Jun. 1983.
466. MONTEITH, R.S. and KINCHEN, S. Foreign trip report: Paraguay, August 23–23,
1987—family planning survey. [Memorandum] Atlanta, Georgia, Centers for Disease
Control, September 17, 1987. 23 p.
467. PERU. INSTITUTO NACIONAL DE ESTADISTICA (INE). and INSTITUTE FOR RESOURCE
DEVELOPMENT/WESTINGHOUSE (IRD/W). Enquesta Demográfica y de Salúd Familiar 1986:
resultados preliminaros. [Demographic and Family Health Survey, 1986: preliminary
results.][SPA] Marzo, Peru, INE, Mar. 1987. 30 p.
468. PROGRAM FOR THE INTRODUCTION AND ADAPTATION OF CONTRACEPTIVE TECHNOLOGY.
Contraceptive use in China. Nov. 1, 1984. 8 p. (Unpublished)
469. PROGRAM FOR THE INTRODUCTION AND ADAPTATION OF CONTRACEPTIVE TECHNOLOGY.
[Description of three IUD projects in China.] [1987]. 2 p. (Unpublished)
470. SHAABAN, M.M., SALAH, M., ZARZOUR, A., and ABDULLAH, S.A. A prospective study of
Norplant implants and the TCu 380Ag IUD in Assiut, Egypt. Studies in Family Planning
14(6–7): 163–169. Jun.-Jul. 1983.
471. SHERRIS, J.D., RAVENHOLT, B.B., BLACKBURN, R., GREENBERG, R.H., KAK, N., PORTER,
R.W., 3rd, and SAUNDERS, S. Contraceptive social marketing: lessons from experience.
Population Reports, Series J, No. 30. Baltimore, Johns Hopkins University, Population
Information Program, Jul.-Aug. 1985. 40 p.
472. SIVIN, I., ALVAREZ SANCHEZ, F., DIAZ, S., HOLMA, P., COUTINHO, E., MCDONALD, O.,
ROBERTSON, D.N., and STERN, J. Three-year experience with Norplant subdermal
contraception. Fertility and Sterility 39(6): 799–808. Jun. 1983.
473. VESSEY, M., DOLL, R., PETO, R., JOHNSON, B., and WIGGINS, P. A long-term follow-up
of women using different methods of contraception—an interim report. Journal of
Biosocial Science 8(4): 375–427. Oct. 1976.
474. WASSERHEIT, J.N., HARRIS, J.R., CHAKRABORTY, J., KAY, B.A., and MASON, K.J.
Reproductive tract infections in a family planning population in rural Bangladesh: a
neglected opportunity to pomote MCH-FP programs. 1988. 36 p. (Unpublished)
475. WORLD HEALTH ORGANIZATION (WHO). DIVISION OF FAMILY HEALTH. Maternal mortality
rates: a tabulation of available information. 2nd ed. Geneva, WHO, 1986. 46 p.
Referencais Adicionales,
1989-1993
476. ANONYMOUS. Copper T 380A approved for eight years of use. Outlook 9(4): 8. Jan.
1992.
477. ALOUI, T., AYAD, M., and FOURATI, H. Enquete Démographique et de Santé en
Tunisie 1988. [Demographic and Health Survey in Tunisia 1988][FRE] Columbia, Maryland,
Office National de la Famille et de la Population, and Institute for Resource
Development/Macro Systems, Oct. 1989. 224 p.
478. ALVAREZ, F., BRACHE, V., FERNANDEZ, E., GUERRERO, B., GUILOFF, E., HESS, R.,
SALVATIERRA, A.M., and ZACHARIAS, S. New insights on the mode of action of intrauterine
contraceptive devices in women. Fertility and Sterility 49(5): 768–773. May 1988.
479. ANDERSSON, J.K., and RYBO, G. Levonorgestrel-releasing intrauterine device in the
treatment of menorrhagia. British Journal of Obstetrics and Gynecology 97: 690–694.
Aug. 1990.
480. ANDERSSON, K., BATAR, I., and RYBO, G. Return to fertility after removal of a
levonorgestrel-releasing intrauterine device and Nova-T. Contraception 46: 575–584.
1992.
481. ANDRADE, A.T.L., PIZARRO, E., SHAW, S.T., SOUZA, J.P., BELSEY, E.M., and ROWE,
P.J. Consequences of uterine blood loss caused by various intrauterine contraceptive
devices in South American women. Contraception 38(1): 1–18. Jul. 1988.
482. ANWAR, M. An evaluation of IUD insertion by a non-clinical delivery system.
Advances in Contraception 8: 303–312. 1992.
483. APELO, R.A., and WASZAK, C.S. Postpartum IUD insertion in Manila, Philippines.
Advances in Contraception 1: 319–328. 1985.
484. ARBAB, A.A.O., MCNAMARA, R., LAURO, D. and AZIZ, F.A. Expanded services for
intrauterine contraception in Sudan. East African Medical Journal 68(2): 70–73. Feb.
1991.
485. ARUMUGAM, K., and CHRISTINA, T.F.M. Fertility after removal of Multiload Cu 250
intrauterine device. British Journal of Family Planning 16: 130–131. 1991.
486. ARUMUGAM, K., and CHRISTINA, T.F.M. Return of fertility after long-term use of the
intrauterine device. Medical Sciences Research 19: 183. 1991.
487. ASSOCIATION FOR VOLUNTARY SURGICAL CONTRACEPTION. Postpartum IUD insertion:
Clinical and programmatic guideline. Mar. 1993.
488. ATRASH, H.K., FRYE, A., and HOGUE, C.J. Incidence of morbidity and mortality with
IUD in situ in the 1980s and 1990s. In: Bardin, C.W. and Mishell, D.R., Jr., eds.
Proceedings from the 4th International Conference on IUDs. Boston, Butterworth-Heinemann,
1994. p. 76–87.
489. AYAD, M., SAYED, H.A.-A., and WAY, A.A. Policy implications of the DHS findings
for Egypt, Morocco and Tunisia. Proceedings of the Demographic and Health Surveys World
Conference, Aug. 5–7, 1991, Washington D.C. (Vol. 3). Columbia, Maryland, IRD/Macro
International, 1991. p. 2037–2051.
490. AZELMAT, M., AYAD, M., and BELHACHMI, H. Enquete National sur la Planification
Familiale, la Fécondité et al Santé de Population au Maroc (ENPS) 1987. [National
Survey of Family Planning, Fertility,and Health of the Population of Morocco 1987][FRE]
Columbia, Maryland, Morocco Ministere de la Santé Publique, Service des Etudes et de
l’Information Sanitaire. and Institute for Resource Development/Westinghouse. Mar.
1989. 187 p.
491. BATAR, I. Clinical experiences with MLCu250 and MLCu375 IUD. Advances in
Contraception 8: 73–80. 1992.
492. BATAR, I. One-year clinical experience with Flexigard. Contraception 46:
307–12. 1992.
493. BATAR, I., LAMPE, L.G., and ALLONEN, H. Clinical experience with intrauterine
contraceptive devices (IUDs) inserted with and without tail. Acta Chirurgica Hungarica
29(4): 385–93. 1988.
494. BRENNER, P.F. A clinical trial of the Delta-T intrauterine device: immediate
postpartum insertion. Contraception 28: 135–147. 1983.
495. BUCHAN, H., VILLARD-MACKINTOSH, L., VESSEY, M., YEATES, D., and MCPHERSON, K.
Epidemiology of pelvic inflammatory disease in parous women with special reference to
intrauterine device use. British Journal of Obstetrics and Gynaecology 97: 780–788.
Sept. 1990.
496. CHAMPION, C.B., BEHLILOVIC, B., AROSEMENA, J.M., RANDIC, L., COLE, L.P., and
WILKENS, L.R. A three-year evaluation of TCu 380Ag and Multiload Cu 375 intrauterine
devices. Contraception 38(6): 631–639. Dec. 1988.
497. CHI, I.-C. An evaluation of the levonorgestrel-releasing IUD: Its advantages and
disadvantages when compared to the copper-releasing IUDs. Contraception 44(6):
573–588. Dec. 1991.
498. CHI, I.-C., and FARR, G. Postpartum IUD contraceptionA review of an international
experience. Advances in Contraception 5(3): 127–146. Sep. 1989.
499. CHI, I.-C., POTTS, M., WILKENS, L.R., and CHAMPION, C.B. Performance of the Copper
T-380A intrauterine device in breastfeeding women. Contraception 39(6): 603–618. Jun.
1989.
500. CIMBER, H., DREHER, E., MUHLEMANN, M., and MALL-HAEFELI, M. Intrauterine occlusion
body (IUB): Preliminary report. Contraception 37(5): 503–516. May 1988.
Population Reports is published by the Population Information Program, Center for Communication Programs, The Johns Hopkins School of Public Health, 111 Market Place, Suite 310, Baltimore, Maryland 21202-4012, USA
Palavras chave: p, intrauterine, p , fertility, 1, journal, s, family, 1985, health, american journal, family planning , eds, dec, rwanda, population, and , american journal obstetrics, 1985 p, rosenfield ag,
conteúdos relacionados
Search_LibdocFree @SearchWordsAux='Bibliografia - 2ª Parte p, intrauterine, p , fertility, 1, journal, s, family, 1985, health, american journal, family planning , eds, dec, rwanda, population, and , american journal obstetrics, 1985 p, rosenfield ag, ',@type='ARTICLE', @libdocidant=12808, @max_rows=10, @key_rank=0- Artigo / Publicado em 22 de agosto de 2000
-
Bibliografia - 1ª Parte
- Artigo / Publicado em 13 de novembro de 2000
-
Bibliografia - 3ª Parte
- Artigo / Publicado em 13 de novembro de 2000
-
Bibliografia - 2ª Parte
- Artigo / Publicado em 22 de agosto de 2000
-
Bibliografia - 1ª Parte
- Artigo / Publicado em 15 de maio de 2006
-
08 - Bibliografia
- Notícia / Publicada em 13 de janeiro de 2022
-
Estudo diz: “prescreva aspirina com base na relação risco-benefício, e não na idade”
- Notícia / Publicada em 24 de março de 2014
-
Gestantes com sobrepeso e obesidade: qual é o efeito sobre o crescimento fetal?
- Notícia / Publicada em 15 de fevereiro de 2011
-
Parto à noite aumenta o risco de encefalopatia neonatal
- Notícia / Publicada em 1 de novembro de 2010
-
O uso de câmaras de bronzeamento artificial na Islândia aumentou a incidência de melanoma
- Notícia / Publicada em 25 de agosto de 2010
-
Mulheres obesas tem maior risco de complicações anestésicas durante cesariana